Abstract
In the letter from Yoshida et al. entitled ”Successful salvage endoscopic mucosal resection for residual superficial hypopharyngeal carcinoma after chemoradiotherapy, with long-term survival,” the authors report the successful treatment of residual cancer with endoscopic mucosal resection (EMR) after chemoradiotherapy for advanced hypopharyngeal cancer. This report suggests that salvage EMR might be a treatment option for residual or recurrent hypopharyngeal cancer after chemoradiotherapy, although only salvage surgery or chemotherapy have been the treatment options so far. Discussion about the efficacy and safety with an increased number of cases is needed; however, three issues are noted.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
